Monday, June 22, 2015 4:33:45 PM
IF efficacy news hits, this will run hard, and you can buy into the run, thus eliminating SUBSTANTIAL RISK and still maintaing most of the gain. The gain will not be instantaneous, as it will take at least 1-2 days for the news to fully circulate.
IF news is bad, this will drop harder and faster than you can imagine. You won't be able to get out in time. I sold a few days ago and am patiently awaiting efficacy news.
MEANWHILE....AMDA is killing it with FDA approval for their drug already in other countries. Stock had massive gains today, with $!+ in the very near future. FDA approval is expected anyday. Take those profits and roll them into PPCH. Timing is perfect for this play.
Recent PPCB News
- Biopharma on a Tear After Certificate of Grant from Japanese Patent Office • AllPennyStocks.com • 06/25/2024 04:26:00 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM